268 related articles for article (PubMed ID: 15808838)
1. Role of p38alpha MAPK in cardiac apoptosis and remodeling after myocardial infarction.
Ren J; Zhang S; Kovacs A; Wang Y; Muslin AJ
J Mol Cell Cardiol; 2005 Apr; 38(4):617-23. PubMed ID: 15808838
[TBL] [Abstract][Full Text] [Related]
2. Growth differentiation factor 5 regulates cardiac repair after myocardial infarction.
Zaidi SH; Huang Q; Momen A; Riazi A; Husain M
J Am Coll Cardiol; 2010 Jan; 55(2):135-43. PubMed ID: 20117381
[TBL] [Abstract][Full Text] [Related]
3. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
[TBL] [Abstract][Full Text] [Related]
4. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction.
Odashima M; Usui S; Takagi H; Hong C; Liu J; Yokota M; Sadoshima J
Circ Res; 2007 May; 100(9):1344-52. PubMed ID: 17395874
[TBL] [Abstract][Full Text] [Related]
6. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
[TBL] [Abstract][Full Text] [Related]
7. Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis.
Li GH; Shi Y; Chen Y; Sun M; Sader S; Maekawa Y; Arab S; Dawood F; Chen M; De Couto G; Liu Y; Fukuoka M; Yang S; Da Shi M; Kirshenbaum LA; McCulloch CA; Liu P
Circ Res; 2009 Apr; 104(7):896-904. PubMed ID: 19246681
[TBL] [Abstract][Full Text] [Related]
8. Cardiomyocyte-specific overexpression of human stem cell factor improves cardiac function and survival after myocardial infarction in mice.
Xiang FL; Lu X; Hammoud L; Zhu P; Chidiac P; Robbins J; Feng Q
Circulation; 2009 Sep; 120(12):1065-74, 9 p following 1074. PubMed ID: 19738140
[TBL] [Abstract][Full Text] [Related]
9. Myocardial expression of a dominant-negative form of Daxx decreases infarct size and attenuates apoptosis in an in vivo mouse model of ischemia/reperfusion injury.
Roubille F; Combes S; Leal-Sanchez J; Barrère C; Cransac F; Sportouch-Dukhan C; Gahide G; Serre I; Kupfer E; Richard S; Hueber AO; Nargeot J; Piot C; Barrère-Lemaire S
Circulation; 2007 Dec; 116(23):2709-17. PubMed ID: 18025529
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis.
Chen LL; Yin H; Huang J
Cardiovasc Pathol; 2007; 16(4):221-30. PubMed ID: 17637430
[TBL] [Abstract][Full Text] [Related]
11. Class A scavenger receptor attenuates myocardial infarction-induced cardiomyocyte necrosis through suppressing M1 macrophage subset polarization.
Hu Y; Zhang H; Lu Y; Bai H; Xu Y; Zhu X; Zhou R; Ben J; Xu Y; Chen Q
Basic Res Cardiol; 2011 Nov; 106(6):1311-28. PubMed ID: 21769674
[TBL] [Abstract][Full Text] [Related]
12. Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion.
Tada H; Kagaya Y; Takeda M; Ohta J; Asaumi Y; Satoh K; Ito K; Karibe A; Shirato K; Minegishi N; Shimokawa H
Cardiovasc Res; 2006 Aug; 71(3):466-77. PubMed ID: 16781691
[TBL] [Abstract][Full Text] [Related]
13. [Effects of atenolol and metoprolol on cardiomyocyte apoptosis and related gene expression after acute myocardial infarction in rats].
Chen YF; Yang YJ; Chen X; Ruan YM; Sun RC; Tian Y; Zhou YW; Wang QZ; Si WX; Chen JL; Gao RL; Chen ZJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):538-43. PubMed ID: 16995309
[TBL] [Abstract][Full Text] [Related]
14. Dominant-negative p38alpha mitogen-activated protein kinase prevents cardiac apoptosis and remodeling after streptozotocin-induced diabetes mellitus.
Thandavarayan RA; Watanabe K; Ma M; Gurusamy N; Veeraveedu PT; Konishi T; Zhang S; Muslin AJ; Kodama M; Aizawa Y
Am J Physiol Heart Circ Physiol; 2009 Sep; 297(3):H911-9. PubMed ID: 19617408
[TBL] [Abstract][Full Text] [Related]
15. Syndecan-4 signalling inhibits apoptosis and controls NFAT activity during myocardial damage and remodelling.
Echtermeyer F; Harendza T; Hubrich S; Lorenz A; Herzog C; Mueller M; Schmitz M; Grund A; Larmann J; Stypmann J; Schieffer B; Lichtinghagen R; Hilfiker-Kleiner D; Wollert KC; Heineke J; Theilmeier G
Cardiovasc Res; 2011 Oct; 92(1):123-31. PubMed ID: 21632883
[TBL] [Abstract][Full Text] [Related]
16. TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction.
Tian H; Cimini M; Fedak PW; Altamentova S; Fazel S; Huang ML; Weisel RD; Li RK
J Mol Cell Cardiol; 2007 Dec; 43(6):733-43. PubMed ID: 17945252
[TBL] [Abstract][Full Text] [Related]
17. Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice.
Thandavarayan RA; Watanabe K; Sari FR; Ma M; Lakshmanan AP; Giridharan VV; Gurusamy N; Nishida H; Konishi T; Zhang S; Muslin AJ; Kodama M; Aizawa Y
Free Radic Biol Med; 2010 Nov; 49(9):1422-31. PubMed ID: 20705132
[TBL] [Abstract][Full Text] [Related]
18. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
19. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.
Most P; Seifert H; Gao E; Funakoshi H; Völkers M; Heierhorst J; Remppis A; Pleger ST; DeGeorge BR; Eckhart AD; Feldman AM; Koch WJ
Circulation; 2006 Sep; 114(12):1258-68. PubMed ID: 16952982
[TBL] [Abstract][Full Text] [Related]
20. Prevention of cardiac remodeling after myocardial infarction in transgenic rats deficient in brain angiotensinogen.
Lal A; Veinot JP; Ganten D; Leenen FH
J Mol Cell Cardiol; 2005 Sep; 39(3):521-9. PubMed ID: 15950985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
